Moderna Chief Legal Officer Shannon Thyme Klinger to Retire in March 2027
Moderna Chief Legal Officer Shannon Thyme Klinger will retire, with her employment set to end on March 31, 2027, the company said in an 8-K filed Friday.
Moderna entered into a transitional services and retirement agreement with Klinger on Nov. 13, according to the filing. She will keep working until the March 31 retirement date, transition her duties as the company requests, and be deemed to have resigned from all officer positions on the earlier of that date or a date Moderna designates.
Pay through retirement
Until she retires, Klinger will keep her current base salary and benefits and continue to vest in outstanding equity awards, the 8-K says. She is eligible for a 2026 bonus equal to her target bonus multiplied by the corporate performance factor set by Moderna's board.
After the retirement date, she will receive severance of $1,628,300, equal to 12 months of base salary plus her current annual target bonus, paid in installments over 12 months. Moderna will also pay her COBRA premiums until Sept. 30, 2028, subject to earlier termination in certain cases.
Payments tied to litigation
The agreement links additional payments to two sets of lawsuits, according to the filing:
- $2,500,000 if Moderna is the prevailing party when all current and related future litigation with Arbutus Biopharma Corporation and Genevant Sciences, GmbH concludes
- Up to $5,500,000 depending on the result of current and related future litigation with Pfizer, Inc., BioNTech SE and related parties
The 8-K does not name a successor.
Sources
- Form 8-K, Moderna, Inc., filed Nov. 13, 2026, accession 0001682852-26-000205
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence. SI may make mistakes.